deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT02001324

HMB- Data Collection Methods

Patient-based Outcomes for Heavy Menstrual Bleeding: Comparisons of Treatments and Methods of Data Collection

Sponsor: Women and Infants Hospital of Rhode Island

Updated 6 times since 2017 Last updated: Aug 23, 2021 Started: Mar 31, 2013 Primary completion: Jul 31, 2015 Completion: Dec 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

this pilot project is no longer funded

This NA trial investigates Heavy Menstrual Bleeding and is currently terminated or withdrawn. Women and Infants Hospital of Rhode Island leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotTerminated~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Sep 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Sep 2021 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Women and Infants Hospital of Rhode Island
Data source: Women and Infants Hospital of Rhode Island

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations